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The misuse of anabolic-androgenic steroids by athletes and non-athletes causes harmful effects on the central nervous 
system. In Ayurvedic medicine, Withania somnifera (WS) as an herbal drug has been reported for several functions 
including adaptogenic, anticonvulsant, cytoprotective and antioxidant. The present study investigated the neuroprotective 
functions of WS (100, 200 and 400 mg/kg body weight) in nandrolone decanoate (ND)-induced (16 mg/kg body weight) 
brain injury in male Wistar rats. ND was injected intramuscularly twice weekly for 4 weeks. The water emulsion of WS root 
powder was administered orally once daily for 30 days to ND-treated rats. At the end of the experiment, anxiety-like 
behaviour was assessed in rats using the elevated plus maze. Haematoxylin-and-eosin-stained coronal sections of the parietal 
cortex and hippocampus of ND rats showed severe alterations in brain histology compared with control rats. 
Acetylcholinesterase (AChE) activity in the striatum and prodynorphin gene expression in the hippocampus was 
significantly elevated in the ND group compared with the control group. Treating ND induced rats with various doses of 
WS significantly reversed the brain damage, anxiety behaviour, increased striatal AChE activity and reduced prodynorphin 
gene expression in the hippocampus. In conclusion, WS extract can be used as a neuroprotective agent to reduce the effects 
of anabolic steroids. 
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Anabolic androgenic steroids (AASs) are synthetic 
derivatives of the male gonadal hormone testosterone 
and are used clinically and illegally1. They are 
employed for the treatment of male hypogonadism, 
burns, surgery, trauma, anaemia, radiation therapy, 
HIV and metastatic breast tumors2-4. However, due to 
their beneficial role in tissue building, maintenance of 
muscle mass and strength, they have been widely used 
by adults, adolescents and athletes in their attempt to 
strengthen their muscle development and to promote 
recovery5. The therapeutic dose of ND recommended 
varies from 50 to 100 mg per week for women and 
100 to 200 mg per week for men6. An individual who 
takes a dose that is 10-100 fold higher than the 
standard dose can be subjected to many adverse 
effects7. AAS abuse is implicated with psychiatric 
symptoms such as mania, depression, aggression and 
the development of dependence; behavioural changes 
like increased irritation; acute psychosis and anxiety8.  
The striatum is a part of the brain that contains 
myriad cholinergic pathways and clinical evidence 
suggests that excessive AAS concentrations may 
damage the cholinergic system, which executes 
several vital functions like learning, memory and the 
organization of movements9. The Acetylcholinesterase 
(AChE) hydrolyses the neurotransmitter acetylcholine 
(ACh) in cholinergic synapses as well as in 
neuromuscular junctions; this action rapidly 
terminates the transmission of nerve impulses10. The 
hippocampus area of brain which is implicated mainly 
in learning and memory functions of rat has a 
relatively high density of androgen receptors, 
implicating a possible link between cognitive function 
and androgen receptors11. AASs induce hippocampal 
apoptosis and inhibit hippocampal neurogenesis, 
suggesting that AASs could reduce hippocampal 
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volume, which could be a basis for the AAS-
associated spatial memory impairments that have 
been observed in human and animal studies12. 
Previous studies have shown that administration of 
the AAS nandrolone decanoate (ND) elevated the 
prodynorphin messenger RNA (mRNA) level in male 
rat hippocampus and also affected the dynorphinergic 
system by altering the level of dynorphin B13. Other 
works support plausible correlations between 
impaired memory and dynorphin levels, and 
researchers suggest that the dynorphinergic system 
modulates learning and memory14. Gonadal hormones 
exhibit intricate role in cognitive processes, and thus 
it is conceivable that cognitive functions are 
influenced by AASs15. AASs appear to upregulate 
androgen receptors in the hippocampus, cerebral 
cortex and hypothalamus16. Long-term AAS abusers 
are characterized by a high level of anxiety and 
extreme mood swings17. Chronic infusion of high 
doses of ND induces anxiolytic behaviour and impairs 
social memory, spatial learning and recall performance 
via., activation of central androgen receptors18. There 
is only limited data on the impact of ND in the CNS.  
Withania somnifera Linnaeus Dunal (Family 
Solanaceae), hereafter WS, is a notable herb in 
Ayurveda, Indian traditional medicine19. WS has 
adaptogenic, antistress, anticonvulsant, cytoprotective, 
neuroprotective and antioxidant properties20. Earlier 
works have demonstrated the protective effect of WS 
on age-related neurodegenerative diseases like 
Parkinson’s and Alzheimer’s diseases21. WS reduces 
the levels of AChE activity in the brain of 
scopolamine induced amnesic mice22. The cognitive 
and psychomotor performance was improved 
following WS extract intake in healthy human 
participants implicating increased cortical muscarinic 
ACh receptor capacity. This ability might partly 
explicate the cognition-enhancing and memory-
improving functions of WS extracts in animals and in 
humans23. In addition, WS treatment can reduce 
anxiolytic activity24. Our recent work revealed the 
therapeutic benefits of a water emulsion of WS root 
powder on ND-induced biochemical alterations and 
hepatorenal toxicity25. However, the protective and 
beneficial function of WS in ND-induced brain injury 
is not known. The present study investigated the 
neuroprotective potentials of WS on ND-induced 
injury to the parietal cortex, striatum and hippocampus 
of brain and assessed anxiety-like behaviour in mice. 
Materials and Methods 
Animals 
Thirty-six male Wistar rats (180-250 g) were 
acquired from Biogen Laboratory Animal Facility 
(Registered Lab Animal Breeders, Bangalore, India) 
and maintained at the Centre for Laboratory Animal 
Research (CLAR) facility of the institution. The 
animals were housed three per cage in a controlled 
environment with free access to food and water ad 
libitum at a temperature of 25±2°C, humidity 40%-
60% and a natural light/dark cycle. All animal 
procedures were approved by institutional animal 
ethics committee (IAEC) of Saveetha Medical 
College (IAEC number: SU/CLAR/RD/004/2018). 
Animal experiments were carried out as per the 
guidelines of the Committee for the Purpose of 
Control and Supervision of Experimentation on 
Animals (CPCSEA, New Delhi, India). 
Materials 
The reagents and chemicals used in this study were 
obtained from Sigma Aldrich Chemical Company, St. 
Louis, MO, U.S.A Primer Premier software, Premier 
Biosoft, USA was used for the design of primers and 
also confirmed with the Primer-BLAST tool from the 
National Center for Biotechnology Information 
(NCBI) website. All the primers were synthesized by 
Sigma Genosys (Bangalore, India). M-MuLV Reverse 
Transcriptase and RNase Inhibitor were purchased 
from Fermentas (Thermo Scientific), USA The list of 
primers used is shown in Table 1. 
Drug treatment 
WS tablets (Himalaya Drug Company, Bangalore, 
India) were used in this study; each tablet contained 
250 mg of root extract and was prepared in distilled 
water. ND (decadurabolin or 4-oestren-17β-01-3-one-
17-decanoate) was purchased from Cadila Health
Care Ltd. (Goa, India; 100 mg/mL ampules). ND was
diluted in corn oil.
The randomly segregated rats were divided into 
five groups: (n = 6 each for the ND+WS100 and 
ND+WS400 groups; n= 8 each for the other groups) 
Table 1 — Primers used for reverse transcription-polymerase chain reaction amplification 
Gene Forward primer (5′→3′) Reverse primer (5′→3′) Product size (bp) 
Prodynorphin ATGGCGTGGTCCAGGCTGATGC AGTTTGTAGATTTAGAAGCCTTATCC 400 
β-actin CATCTCTTGCTCGAAGTCCA ATCATGTTTGAGACCTTCAACA 162
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Group 1: Vehicle control (C; n = 8) – Rats injected 
with 1 mL corn oil/kg body weight intramuscularly 
(i.m.) in the lateral aspect of thigh twice weekly for 4 
weeks. 
Group 2: ND (n = 8) – Rats received 16 mg/kg ND 
(i.m. in 1 mL corn oil/kg body weight) in the lateral 
aspect of thigh twice weekly for 4 weeks. 
Group 3: ND+WS 100 (n = 6) – Rats received 16 
mg/kg ND (i.m. in 1 mL corn oil/kg body weight) 
twice weekly for 4 weeks and oral WS extract (100 
mg/kg body weight) once daily for 30 days. 
Group 4: ND+WS 200 (n = 8) – Rats received 16 
mg/kg ND (i.m. in 1 mL corn oil/kg body weight) 
twice weekly for 4 weeks and oral WS tablets (200 
mg/kg body weight) once daily for 30 days. 
Group 5: ND+WS400 (n = 6) – Rats received 16 
mg/kg ND (i.m. in 1 mL corn oil/kg body weight) 
twice weekly for 4 weeks and oral WS tablets (400 
mg/kg) once daily for 30 days.  
The animals were weighed before the beginning of 
the experiment and on days 11, 21 and 31 of the 
experiment. A week after the last ND injection, the 
animals were anaesthetised with isoflurane and 
sacrificed by cervical dislocation. The brain was 
carefully dissected, washed in ice-cold saline and 
weighed. The parietal cortex, hippocampus and 
striatum were excised. The parietal cortex and 
hippocampus were used for haematoxylin and eosin 
(H&E) staining, the striatum was used to evaluate 
AChE activity and the hippocampus was used to 
examine gene expression. 
Histopathological evaluation 
The parietal cortex and hippocampus were fixed in 
10% phosphate-buffered formalin (pH 7.5), processed 
by routine histological methods and embedded in 
paraffin blocks. Five micrometer thick coronal 
sections were cut with a microtome. All sections were 
stained with H&E and viewed under a light 
microscope (Olympus iNEA, CH20iBIMF, Olympus 
Opto Systems India Pvt. Ltd, Noida, India). 
AChE activity 
AChE activity was assessed in homogenates of 
striatum following a modification of the method 
reported by Srikumar et al26. The mixture was set by 
mixing 0.4 mL of the homogenate with 2.6 mL 
phosphate buffer (0.1 M, pH 8.0) and 100 μL of 
Elman’s reagent (270 μM). This mixture was then 
pre-incubated for 2 min at 30ºC and the reaction was 
triggered with the addition of 20 μL Acetylthiocholine 
(30 mM). The product of thiocholine reaction with 
Elman’s reagent was measured every 2 min for 10 
min at 412 nm. The absorbance per minute was 
measured. The specific activity is expressed as μmol 
ACTC/min/mg protein. 
Reverse transcription polymerase chain reaction (RT-PCR) 
Bilateral hippocampi were collected from each rat 
and placed on an ice plate. Fifty to hundred 
milligrams of tissue were treated with 1 mL pre-cold 
TRIzol (Thermo Fischer Scientific, USA) and then 
sufficiently ground with a tissue grinding appliance. 
The homogenates were then incubated on ice for 5 
min. Next, added 0.2 mL chloroform to the 
homogenates and were drastically agitated for 15 sec 
and then incubated on ice for 2-3 min. After 
completing the centrifugation step at 12,000 g for 15 
min, the supernatant was removed and mixed with 0.5 
mL isopropanol and incubated at room temperature 
for 5-10 min. This solution was subsequently 
centrifuged at 12,000 g for 10 min at 4°C and the 
supernatant carefully removed. The pellet was washed 
with 0.5 mL of freshly made 75% ethanol and 
centrifuged at 6,300 g for 5 min at 4°C. The 
supernatant was then discarded and the pellet was 
dried at room temperature and then dissolved in water 
with 1 g/L diethyl pyrocarbonate (DEPC) for a final 
concentration of 0.1 μg/µL RNA. 
An ultraviolet spectrophotometer was used to 
measure the RNA concentration and quality (using a 
10-20-fold dilution). The absorbance at 260 nm was
used to determine the concentration (μg/μL) and the
260/280 ratio was used to determine the purity
(required to be 1.8-2.0). The RNA integrity was
confirmed by agarose gel electrophoresis, observing
the 28S, 18S and 5S bands on a gel stained with
ethidium bromide using a gel imaging system
(ProGen Gel Doc system, Progen Scientific store,
London, UK). Five micrograms of total RNA were
uncoiled by heating at 70°C for 10 min and then
reverse transcribed into complementary DNA (cDNA)
in a 20 µL reaction in a sterile nuclease-free tube.
Each reaction contained 1 µL Oligo (dT) primer,
7.5 µL DEPC-treated water, 4 µL 5X reaction buffer,
0.5 µL (20 U) RNase Inhibitor, 2 µL of a 10 mM
dNTP mix and 2 μL (40 U) M-MuLV Reverse
Transcriptase. The mixture was mixed gently and
centrifuged briefly. It was incubated at 37°C for 1 h,
followed by 70°C for 10 min to stop the reaction.
A portion of the cDNA (2 µL) was amplified in a
50 µL reaction volume containing 4.0 µL of the
prodynorphin forward primer (2 µM), 4.0 µL of the
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prodynorphin reverse primer (2 µM) (Sino biological, 
China), 3.0 µL of the β-actin forward primer (2 µM), 
3.0 µL of the β-actin reverse primer, 5.0 µL 10X 
buffer, 5.0 µL of a 2 mM dNTP mix, 0.5 µL Taq 
DNA polymerase (5 U/µL), 2.0 µL template and 23.5 
µL sterile distilled water. PCR amplification was 
carried out in an Eppendorf Mastercycler® ep 
(Eppendorf AG, Hamburg, Germany). The thermal 
cycling conditions were: initial denaturation at 94°C 
for 5 min; 34 cycles of 94°C for 40 s, 65°C for 60 s 
and 72°C for 60 s and a final extension at 72°C for 
10 min. The amplified products were separated on a 
1.0% agarose gel in 1X Tris–Borate–ethylene-
diaminetetraacetic acid (TBE) at 75 V for 3 h. The gel 
was stained with ethidium bromide and the amplified 
product was visualized and photographed on a 
ProGen Gel Doc system.  
Elevated plus maze (EPM) 
The day after final ND injection, the rats were 
subjected to EPM test for 3 min to evaluate the level 
of anxiety. The maze consists of two perpendicular 
open arms (50 × 10 cm) without side walls and two 
closed arms (50 × 10 × 50 cm) extending 
horizontally at right angles from a central area (10 × 
10 cm). The maze was elevated to a height of 50 cm 
above the ground. At the beginning of the 
experiment, the rat was placed in the centre of the 
EPM facing the open arm and allowed to freely 
explore the maze for 3 min. The parameters analyzed 
were as follows: open and closed arms entries in 
numbers, the time spent exploring the closed and 
open arms, the percentage of time spent in the open 
arm and the number of entries into the open arms. 
An arm entry is counted when the animal enters the 
arm with all four paws. 
Statistical analysis 
We performed one-way analysis of variance 
(ANOVA) for the data analysis. The values are 
presented as mean ± standard error of the mean (SEM). 
Differences between the means of groups were 
analysed by the Student–Newman–Keuls method. 
p < 0.05 was considered statistically significant. 
Results 
Brain weight 
Brain weight results showed no difference between 
the control group and the treatment groups and the 
values were not statistically significant (Table 2, 
p= 0.906). 
Histopathological evaluation 
Histopathological evaluation of the parietal cortex 
of the control group revealed normal pattern of 
morphology of neurons with all neuronal cell types 
such as the pyramidal cells, stellate cells and granule 
cells with distinct nuclei (Fig. 1a). In the ND group, 
there were immature cells and hyperchromatic dead 
neurons (seen at lower magnification; data not 
shown), apoptotic neurons with pyknotic nuclei 
(Fig. 1b). In the ND+WS100 group (Fig. 1c), there 
were perineural cells (seen at lower magnification; 
data not shown), neuroglial cells, pyramidal cells and 
fewer pyknotic nuclei compared with the ND group. 
In the ND+WS200 group (Fig. 1d), there was normal 
architecture with compactly arranged granule cells 
with rounded pale vesicular nuclei; the hilum 
comprised large pyramidal cells with long processes, 
astrocytes and microglial cells. In the ND+WS400 
group (Fig. 1e), there was almost normal neuronal 
architecture with less neurodegeneration, and 
prominent nuclei compared with the ND group. 
The histopathological changes noticed in the 
hippocampus are shown in Figure 2. In the control 
group, there were normal neurons in the CA1, CA2 
and CA3 regions with three distinct layers, namely 
polymorphic, pyramidal and ganglion (Fig. 2a). By 
contrast, in the ND group (Fig. 2b), there was 
neuronal loss, a thin dentate gyrus with sparse and 
scattered hilar cells in the granular layer with 
numerous immature and apoptotic neuronal cells, cell 
shrinkage and nuclear condensation. In addition, the 
thickness of the CA1, CA2 and CA3 neuronal cell 
layers was remarkably decreased due to severe 
neurodegeneration. In the ND+WS100 group 
(Fig. 2c), nuclear condensation was less severe 
compared with the ND group. In the ND+WS200 
group   (Fig. 2d),    nuclei  were  less  condensed   and  
Table 2 — The effect of WS and ND on the brain weight of male 
Wistar rats 
Group %
Control 0.881 ± 0.0924 
ND 0.768 ± 0.0810 
ND+WS 100 0.762 ± 0.0256 
ND+WS 200 0.767 ± 0.0690 
ND+WS 400 0.836 ± 0.199 
The values are presented as the per cent of body weight
(mean ± standard error of the mean; n = 6 rats per group). There
was no difference between the groups (one-way analysis of 
variance, p=0.906). Abbreviations: ND, nandrolone decanoate;
WS, Withania somnifera. 
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Fig. 1 — Photomicrographs of parietal cortex region of brain stained with H&E. The pictures of the Control (a), ND (b), ND + WS100 
(c), ND + WS 200 (d) and ND + WS 400 (e) groups are shown respectively. Red arrow – neuroglial cells; long black arrow- apoptotic 
neurons; white arrow- pyramidal cells; small black arrow- normal neuronal cells. Magnification 100x. 
Fig. 2 — Photomicrographs of brain hippocampal region stained with H&E. (a) Control rats showed normal neurons with CA1, CA2 and 
CA3 regions (arrow mark) in hippocampus. (b) ND group showed neuronal loss, cell shrinkage and nuclear condensation (black arrow
head) with numerous immature and apoptotic neuronal cells. Panel B1 shows higher magnification (100x) of ND group with arrow head 
depicting apoptotic neurons with pyknotic nuclei. (c) ND+WS100 group showed thin Dentate gyrus, granule cell layer in Dentate gyrus
containing sparse and scattered few hilar cells (arrow marks).(d) In ND+WS200 group, nucleus was less condensed with minimal damage 
(black arrow mark) (e) In ND+WS400 group, nuclear condensation was more minimized, cell shrinkage was dramatically reduced
(orange arrow head). All images captured at 20x magnification except panel B1. 
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tissue damage was reduced compared with the ND 
group. In the ND+WS400 group (Fig. 2e), there was 
markedly less nuclear condensation and cell shrinkage 
compared with the ND group. 
AChE activity in the striatum 
Figure 3 shows the AChE activity measurements in 
the striatum. The values (mean ± SEM, in µmol 
ACTC/mg protein) were: control = 0.333 ± 0.009; ND 
= 2.49 ± 0.117; ND+WS100 = 2.55 ± 0.142; 
ND+WS200 = 0.924 ± 0.117; and ND+WS400 = 1.39 
± 0.113. The AChE activity of the ND group 
increased by 86.6% compared with the control; the 
average value is beyond the reference range for rats. 
ND+WS200 and ND+WS400 groups showed 
significantly reduced AChE activity compared with 
the ND group (62% and 44%, respectively, 
p<0.001). No significant difference was noticed 
between the ND and ND+WS100 AChE activity 
(p=0.704). Considering the WS treatment groups, the 
ND+WS200 group showed more protection than the 
ND+WS100 and ND+WS400 groups (p<0.05). 
Prodynorphin mRNA expression in the hippocampus  
The prodynorphin mRNA level in the hippocampus 
was significantly higher in the ND compared with the 
control group (Fig. 4, p<0.05). Compared with the 
ND group, the prodynorphin mRNA level in the 
ND+WS200 and ND+WS400 was significantly 
reduced (p<0.05). There was no difference between 
the ND and ND+WS100 groups. 
EPM analysis 
As shown in the Table 3, during the 3 min 
exploration of maze, the comparison between rats of 
the ND group and control group didn’t reveal any 
significant difference in the total time spent in the 
centre of EPM despite a marginal increase seen in 
ND group and it was not statistically significant 
(C=7.125±2.799, ND=31.000±15.450; p=0.112). 
The comparison between ND and WS treatment 
groups did not reveal any significant difference in the 
total time spent in the centre of EPM (ND= 
31.000±15.450, ND+WS100= 35.000±6.78, ND+ 
WS200=33.86 ± 13.04, ND+WS400=5.000±1.7; 
p=0.112). The rats of ND group showed significant 
decrease in the total time spent in the closed 
arms compared with control and WS treatment 
groups (C=172.62±2.8, ND=123.50±14.8ND+WS100= 
135.2±10.58, ND+WS200=143.8 ± 17.8, ND+WS400= 
173.00 ± 2.16; p=0.015). This was found to be 
statistically significant (p=0.015). The rats of the ND 
group significantly increased the total time and the 
frequency in the open-arm entries compared to 
the control group of rats (C= 0.000±0.000, 
ND= 43.250±17.866; n=8, p=0.019), while the 
Fig. 3 — AchE activity measurements in brain striatum.
The values present the mean + standard error (n = 6 each group).
p< 0.001 aSignificantly different from the control group;
bSignificantly different from the ND group 
Fig. 4 — Gel picture showing the Prodynorphin gene expression
analysis in hippocampal region of brain (A). Lane 1 - marker, lane 
2 - Control, lane 3 - ND, lane 4 - ND + WS100, lane 5 - ND + 
WS200, lane 6 - ND + WS400. The relative gene expression
(prodynorphin/β-actin ratio) in various groups is shown as bar
graph (B). The values present the mean + standard error (n = 4). 
p< 0.05 aSignificantly different from the control group;
bSignificantly different from the ND group 
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ND+WS groups of rats showed similar open-arm 
entries as such of the control group (ND+WS100 = 
10.17±7.441, ND+WS200 = 10.000±4.614, ND+ 
WS400= 02±02, p> 0.05).Thus more time in the open 
arms was spent by ND group compared to the control 
group, while the time spent by ND+WS groups in the 
open arms was similar to the control group. The 
parameters such as time spent and frequency on the 
open arms of the EPM test were increased in ND-
treated rats imparting an anxiolytic-like effect of ND. 
Discussion  
Several seminal studies have shown that ND cause 
brain damage and associated complications due to 
steroid-induced effects27,28. The neurological 
complications associated with ND include abnormal 
and aggressive behaviour, apart from defective 
neurotransmission due to changes in brain chemicals 
such as dopamine, serotonin and noradrenaline29,30. 
While several therapeutic interventions have been 
attempted in the form of synthetic drugs and exercise 
to treat these drug-induced adverse effects31-33, there is 
a lack of studies that have used herbal medicine to 
overcome the side effects of ND. Therefore, there is 
an urgent need to manage ND complications through 
identification of safe drugs to ameliorate such adverse 
effects of ND.  
In previous work, we have shown the possible 
beneficial and protective effects of WS from ND 
toxicity through the evaluation of various 
biochemical and histopathological (liver and kidney) 
parameters25,34. In the present work, we have 
generated concrete evidence to support the brain 
protective functions of WS through behaviour (EPM), 
brain histopathology, striatal AChE activity and 
prodynorphin gene expression in the hippocampus. 
Indeed, this is the first report with mechanistic 
evidence to substantiate the potential of WS to 
counteract ND-mediated effects through the 
assessment of brain prodynorphin mRNA expression. 
The present findings also provide new insights 
into the neuromodulatory functions of WS through 
assessing AChE activity in the striatum. Earlier works 
demonstrated that chronic nandrolone toxicity 
induced behavioural impairments in rats that involved 
anxiolytic-like-behaviour35,36, memory dysfunction, 
and aggressive behaviour with altered levels of brain 
monoamines, ACh, lipid peroxidation, tumour 
necrosis factor and elevated AChE activity32. 
The present EPM results clearly showed that a high 
dose of ND induced aggressive behaviour. The 
mechanism involved in ND-mediated aggressive 
behaviour is glutamate-induced N-methyl-D-aspartate 
receptor (NMDAR) hyperexcitability and decreased 
clearance of extracellular glutamate content29. The 
fact that more time spent by ND group rats in the 
open arm during the EPM test implicates an 
anxiolytic effect due to aggressive and hyperactive 
behaviour. However, treating rats with various doses 
of WS root extract countered the ND-induced 
anxiolytic and hyperactive behaviours. Activation of 
central androgenic receptors (ARs) has been 
implicated to mediate anxiolytic behaviour, impaired 
social memory, spatial learning and recall 
performance following chronic high doses of ND37. 
Earlier studies have proved the beneficial role of WS 
in cognitive functions using various models of 
memory dysfunctions that involve AChE inhibition, 
neurodegeneration, inflammation and oxidative 
stress38,39. Therefore, the neuroprotective potentials of 
WS could be well substantiated based on other 
research works as well as the key findings of the 
present investigation. ND is believed to provoke a 
cascade of inflammatory and apoptotic events 
that involve oxidative injury – including nuclear 
factor kappa-light-chain-enhancer of activated B cells 
(NF-κB), B-cell lymphoma 2 (Bcl-2), second 
mitochondria-derived activator of caspases/direct 
Table 3 — Elevated plus maze results to assess the effect of WS 
on ND toxicity 
Parameter Group Time (s) p 
Control 7.125 ± 2.799 
ND 31.000 ± 15.450 
Centre ND+WS100 35.000 ± 6.78 0.112 
ND+WS200 33.86 ± 13.04 
ND+WS400 5.000 ± 1.7 
Control 172.62 ± 2.8 
ND 123.50 ± 14.8 
Closed ND+WS100 135.2 ± 10.58 0.015 
ND+WS200 143.8 ± 17.8 
ND+WS400 173.00 ± 2.160 
Control 0.000 ± 0.000 
ND 43.25 ± 17.87 
Open ND+WS100 10.17 ± 7.44 0.019 
ND+WS200 10.00 ± 4.614 
ND+WS400 2.000 ± 2.000 
Each rat spent 180 s in the elevated plus maze. The values 
indicate the time spent in the maze centre and closed and open 
arms; they are presented as the mean ± standard error of the mean 
(n = 6 rats for the ND+WS100 and ND+WS400 groups; n = 8 for 
all other groups). The p values are based on one-way analysis of 
variance. Abbreviations: ND, nandrolone decanoate; WS, 
Withania somnifera. 




IAP-binding protein with low PI (SMAC/DIABLO) 
and vesicular monoamine transporter 2 (VMAT2) – to 
induce brain cell degeneration40. The present 
histopathological results provide plausible evidence to 
support the ability of WS extract to reverse those 
degenerative changes in the parietal cortex and 
hippocampus, which could be through inhibition of 
inflammation, apoptosis and oxidative stress41,42.  
The ability of WS root extract to reverse aggressive 
and hyperactive behavioural abnormalities could be 
attributed to its adaptogenic functions and 
pharmacological efficacy in stress management43-44. 
The phytochemical profile of WS has been intensively 




The present work has demonstrated the 
neuroprotective functions of WS root powder against 
ND-induced toxicity. Specifically, WS extract 
ameliorated histopathological abnormalities in several 
brain regions, reduced AChE activity in the striatum, 
increased prodynorphin mRNA expression in the 
hippocampus and counteracted anxiolytic and 
hyperactive behaviour. These findings emphasize that 
WS extract could be a viable and promising protective 
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